Skip to content

The application of HFNC in AECOPD patients

The clinical application of nasal high-flow humidified oxygen therapy in acute exacerbation of chronic obstructive pulmonary disease (COPD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093156
Enrollment
Unknown
Registered
2024-11-29
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AECOPD

Interventions

High flow nasal therapy:None
non-invasive ventilation:None
Nasal cannula:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients clinically diagnosed as AECOPD upon admission, along with respiratory failure, intubation withdrawal plan, or stable disease with NIV treatment

Exclusion criteria

Exclusion criteria: 1) Severe pneumonia, accompanied by pulmonary infiltration affecting more than 2 lung segments or 1 lobe of the lung. 2) coma patients 3) Recent upper respiratory tract surgery or facial trauma 4) Severe Obstructive Sleep Apnea Syndrome 5) Severe arrhythmias or acute coronary syndrome 6) Cardiac arrest with respiration cessation, weak autonomous breathing, paradoxical respiration, or hemodynamic instability due to respiratory failure, or other patients who require urgent tracheal intubation and invasive mechanical ventilation. 7) Severe Type I respiratory failure (PaO2/FiO2 < 100 mmHg) or severe ventilatory dysfunction (pH < 7.30) 8) Poor airway protection capability, with a high risk of aspiration. 9) Severe nasal congestion 10) Patients who refuse to participate in the study or in other research.

Design outcomes

Primary

MeasureTime frame
Intubation rate;

Secondary

MeasureTime frame
oxygenation index;PaCO2;mortality;Symptom and clinical score imrpovement;Total hospital cost;Hospital cost per day;Cost of ventilation or oxygen support;

Countries

China

Contacts

Public ContactGuochao Shi

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

dw12582@rjh.com.cn+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026